Literature DB >> 23543302

Non-aqueous suspensions of antibodies are much less viscous than equally concentrated aqueous solutions.

Charudharshini Srinivasan1, Alisha K Weight, Till Bussemer, Alexander M Klibanov.   

Abstract

PURPOSE: The aim of this study was to markedly lower the viscosities of highly concentrated protein, in particular antibody, formulations. An effective approach elaborated herein for γ-globulin and a monoclonal antibody is to replace aqueous solutions with equimolar suspensions in neat organic solvents.
METHODS: Viscosities of aqueous solutions and non-aqueous suspensions of the model protein bovine γ-globulin and a murine monoclonal antibody were examined under a variety of experimental conditions. In addition, protein particle sizes were measured using dynamic light scattering and light microscopy.
RESULTS: Concentrated suspensions of amorphous γ-globulin powders (up to 300 mg/mL, composed of multi-micron-sized particles) in absolute ethanol and a number of other organic solvents were found to have viscosities up to 38 times lower than the corresponding aqueous solutions. Monoclonal antibody follows the same general trend. Additionally, the higher the protein concentration and lower the temperature, the greater the viscosity benefit of a suspension over a solution.
CONCLUSIONS: The viscosities of concentrated γ-globulin and monoclonal antibody suspensions in organic solvents are drastically reduced compared to the corresponding aqueous solutions; the magnitude of this reduction depends on the solvent, particularly its hydrogen-bonding properties.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23543302     DOI: 10.1007/s11095-013-1017-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

Review 1.  Challenges in the development of high protein concentration formulations.

Authors:  Steven J Shire; Zahra Shahrokh; Jun Liu
Journal:  J Pharm Sci       Date:  2004-06       Impact factor: 3.534

Review 2.  Strategies and challenges for the next generation of therapeutic antibodies.

Authors:  Alain Beck; Thierry Wurch; Christian Bailly; Nathalie Corvaia
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

3.  Viscoelastic characterization of high concentration antibody formulations using quartz crystal microbalance with dissipation monitoring.

Authors:  Ankit R Patel; Bruce A Kerwin; Sekhar R Kanapuram
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

4.  Liquid high concentration IgG1 antibody formulations by precipitation.

Authors:  Susanne Matheus; Wolfgang Friess; Daniel Schwartz; Hanns-Christian Mahler
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

5.  Hydrophobic salts markedly diminish viscosity of concentrated protein solutions.

Authors:  Wei Du; Alexander M Klibanov
Journal:  Biotechnol Bioeng       Date:  2010-11-17       Impact factor: 4.530

6.  On the mechanism of the cold ethanol precipitation method of plasma protein fractionation.

Authors:  C J van Oss
Journal:  J Protein Chem       Date:  1989-10

7.  Structure-activity relationship for hydrophobic salts as viscosity-lowering excipients for concentrated solutions of monoclonal antibodies.

Authors:  Zheng Guo; Alvin Chen; Roger A Nassar; Bernhard Helk; Claudia Mueller; Yu Tang; Kapil Gupta; Alexander M Klibanov
Journal:  Pharm Res       Date:  2012-06-13       Impact factor: 4.200

Review 8.  Protein crystals for the delivery of biopharmaceuticals.

Authors:  Sujit K Basu; Chandrika P Govardhan; Chu W Jung; Alexey L Margolin
Journal:  Expert Opin Biol Ther       Date:  2004-03       Impact factor: 4.388

9.  Crystalline monoclonal antibodies for subcutaneous delivery.

Authors:  Mark X Yang; Bhami Shenoy; Matthew Disttler; Reena Patel; Margaret McGrath; Sergey Pechenov; Alexey L Margolin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-02       Impact factor: 11.205

10.  Low viscosity highly concentrated injectable nonaqueous suspensions of lysozyme microparticles.

Authors:  Maria A Miller; Joshua D Engstrom; Baltej S Ludher; Keith P Johnston
Journal:  Langmuir       Date:  2010-01-19       Impact factor: 3.882

View more
  6 in total

Review 1.  Advanced protein formulations.

Authors:  Wei Wang
Journal:  Protein Sci       Date:  2015-05-01       Impact factor: 6.725

2.  Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.

Authors:  Pilarin Nichols; Li Li; Sandeep Kumar; Patrick M Buck; Satish K Singh; Sumit Goswami; Bryan Balthazor; Tami R Conley; David Sek; Martin J Allen
Journal:  MAbs       Date:  2015       Impact factor: 5.857

3.  Concentration dependent viscosity of monoclonal antibody solutions: explaining experimental behavior in terms of molecular properties.

Authors:  Li Li; Sandeep Kumar; Patrick M Buck; Christopher Burns; Janelle Lavoie; Satish K Singh; Nicholas W Warne; Pilarin Nichols; Nicholas Luksha; Davin Boardman
Journal:  Pharm Res       Date:  2014-06-07       Impact factor: 4.200

4.  Discovery of a chemical modification by citric acid in a recombinant monoclonal antibody.

Authors:  Chris Chumsae; Liqiang Lisa Zhou; Yang Shen; Jessica Wohlgemuth; Emma Fung; Randall Burton; Czeslaw Radziejewski; Zhaohui Sunny Zhou
Journal:  Anal Chem       Date:  2014-08-27       Impact factor: 6.986

5.  Comparison of Strategies in Development and Manufacturing of Low Viscosity, Ultra-High Concentration Formulation for IgG1 Antibody.

Authors:  Vaibhav Deokar; Alok Sharma; Rustom Mody; Subrahmanyam M Volety
Journal:  J Pharm Sci       Date:  2020-09-15       Impact factor: 3.534

Review 6.  Injectable Hydrogels for Cancer Therapy over the Last Decade.

Authors:  Giuseppe Cirillo; Umile Gianfranco Spizzirri; Manuela Curcio; Fiore Pasquale Nicoletta; Francesca Iemma
Journal:  Pharmaceutics       Date:  2019-09-19       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.